Navigation Links
New Study Explores Medical Affairs Capabilities in Mature and High-Growth Markets
Date:8/23/2013

CHAPEL HILL, N.C., Aug. 23, 2013 /PRNewswire/ -- High-performing pharmaceutical and medical device companies are continually adjusting their Medical Affairs structures to cope with industry and market changes. As the global healthcare landscape continues to expand, Medical Affairs executives must build and maintain strong relationships with physicians and other key members of the medical community across the ever-growing worldwide marketplace.   

A new study by leading research and consulting firm Best Practices, LLC examines critical Medical Affairs capabilities in not only mature markets, but also emerging markets and India in particular. Medical Affairs has grown into a global function, especially in India where 89 percent of the companies that participated in the research study have established dedicated Medical Affairs groups in their organization.

To address the needs of Medical Affairs leaders in mature markets as well as developing markets, the study, "Building Best-in-Class Medical Affairs Capabilities In India- A Case Study For High-Growth Emerging Markets," provides executives with need-to-know comparative metrics, executive insights and best practices from Medical Affairs leaders throughout the healthcare industry.

Key topics addressed in the report will:

  • Illustrate How Leading Global and Indian Pharma & Medical Device Companies Structure & Organize Their Medical Affairs Functions Based On Industry & Market Changes
  • Identify Trends Expected To Impact The Allocation Of Resources Across Different Medical Affairs Functions.
  • Analyze How Regulatory Requirements Are Internalized And Managed By Medical Affairs.
  • Describe The Success Factors And Top Current Challenges Regarding Global & Indian Medical Affairs.
  • Identify What Percentage Of Medical Affairs Budget Leading Companies Allocate To Outsourcing.
  • Trace How Successful Medical Affairs Organizations Work Cross-Functionally To Enhance Effectiveness.

This benchmarking research drew participation from 68 Medical Affairs leaders at 50 top pharmaceutical and medical device companies across mature global markets. In addition, the study presents a segment from India-based organizations.

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1230.htm.

For more information on other recent primary research studies, contact us at 919.403.0251, or visit our website at http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study of Mechanism of Action of Ibrutinib in Mantle Cell Lymphoma Published in Blood - Journal of the American Society of Hematology
2. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
3. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
4. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
5. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
6. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
7. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
8. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
9. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
10. Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study
11. EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 28, 2016  The blood testing market in ... to Kalorama Information and The Freedonia Group in a ... acid testing.  The healthcare research firm said that ... blood collection stations and in improving testing at the ... report, Blood Testing Market in China ...
(Date:4/28/2016)... April 28, 2016 Dr. Vivek ... and Ste phen Schmidt ... a leading provider of cloud-based software solutions for life sciences, today ... to bring a wealth of insight to a growing business.  This ... George Phillips joined ArisGlobal in the position ...
(Date:4/28/2016)... 2016  ValGenesis, Inc., the market leader ... today announced that a prominent world provider ... chronic kidney failure has selected ValGenesis Validation ... validation process. The global medical device manufacturer ... manage their validation processes electronically. Upon completion ...
Breaking Medicine Technology:
(Date:4/30/2016)... ... April 30, 2016 , ... A ... use of the HyProCure sinus tarsi implant. ( http://www.cbc.ca/news/canada/ottawa/banned-quebec-dentist-pierre-dupont-working-as-chiropodist-in-ottawa-1.3515494 ) The ... minimally invasive procedure performed, when indicated, to correct the partial displacement of ...
(Date:4/29/2016)... New York (PRWEB) , ... April 30, 2016 , ... ... Dobbs Ferry campus. The following programs will be expanding due to high demand: ... (HRM). The expansion will begin this summer. , School of Business ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula ... brain and mood optimization products to the store is just one more way ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Bernie Siegel, ... seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death live on ... . Dr. Bernie Siegel, author of a plethora of essential books-to-read for ...
(Date:4/29/2016)... ... April 29, 2016 , ... A new ... with severe congenital diaphragmatic hernia have better survival rates if surgery is performed ... (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs into ...
Breaking Medicine News(10 mins):